Security key
75382E208
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT)
CUSIP: 75382E208
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 27,748,559
- Total 13F shares
- 15,619,662
- Share change
- +15,619,527
- Total reported value
- $124,884,006
- Put/Call ratio
- 87%
- Price per share
- $8.00
- Number of holders
- 45
- Value change
- +$124,882,925
- Number of buys
- 44
Report period
Q2 2025
Institutions
45
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 75382E208
Recent filing periods:
Top shareholders of RAPT - RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT) as of Q2 2025
As of 30 Jun 2025,
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value (RAPT) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,619,662 shares.
The largest 10 holders included
Medicxi Ventures Management (Jersey) Ltd, ORBIMED ADVISORS LLC, TCG Crossover Management, LLC, Foresite Capital Management VI LLC, RTW INVESTMENTS, LP, BVF INC/IL, Nantahala Capital Management, LLC, VANGUARD GROUP INC, ADAR1 Capital Management, LLC, and Deep Track Capital, LP.
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q4 2025 Across Filers
Q4 2025 holders
99
Q2 2025 holders
45
Holder diff
-54
| Investor | Q4 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.